Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.  
Dr. Mariana Socal, Associate Scientist at the Johns Hopkins Bloomberg School of Public Health, discusses the FDA’s decision to allow Florida to import prescription drugs from Canada. Alison Taylor, Professor of Ethics at NYU, talks about her book Higher Ground: How Business Can Do the Right Thing in a Turbulent World.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. 

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.   Dr. Mariana Socal, Associate Scientist at the Johns Hopkins Bloomberg School of Public Health, discusses the FDA’s decision to allow Florida to import prescription drugs from Canada. Alison Taylor, Professor of Ethics at NYU, talks about her book Higher Ground: How Business Can Do the Right Thing in a Turbulent World. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Carol Massar and Tim Stenovec bring you reporting from the magazine that helps global leaders stay ahead, plus insight on the people, companies and trends shaping today's complex economy.  Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec bring you reporting from the magazine that helps global leaders stay ahead, plus insight on the people, companies and trends shaping today's complex economy.&nbsp; Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Florida's Canadian Meds, Taking the Higher Ground

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/627615fc-3f35-48ee-8607-b11f00d7d559/transcript

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."
Hosted by Carol Massar and Tim Stenovec

Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.

You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily." Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Bloomberg Businessweek Weekend - December 5th, 2025

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3dcbde72-b89c-4025-b06a-b3aa01035cd3/transcript

Watch Bloomberg Businessweek Daily every day on YouTube: http://bit.ly/3vTiACF.

Netflix Inc. agreed to buy Warner Bros. Discovery Inc., marking a seismic shift in the entertainment business as a Silicon Valley-bred streaming giant tries to swallow one of Hollywood’s oldest and most revered studios.

Under terms of the deal announced Friday, Warner Bros. shareholders will receive $27.75 a share in cash and stock in Netflix, valuing the business at $82.7 billion including debt. The total equity value of the deal is $72 billion. Warner Bros. will spin off cable networks such as CNN and TNT into a separate company before concluding the sale of its studio and HBO to Netflix. 


Media mergers of this scale have a rocky history and this one is expected to bring intense regulatory scrutiny in the US and Europe. Paramount Skydance Corp., which accused Warner Bros. of running an unfair sales process, could also take steps to disrupt the transaction, like by taking an offer directly to shareholders. The company declined to comment.

The Netflix deal combines two of the world’s biggest streaming providers with some 450 million subscribers. Warner Bros.’ deep library of programming gives Netflix content to sustain its lead over challengers like Walt Disney Co. and Paramount.

Today's show features:
Bloomberg News Media and Entertainment Editor Felix Gillette on Netflix agreeing to buy Warner Bros. Discovery Inc. in a deal valuing the business at $82.7 billion including debt
Karin Kimbrough, Chief Economist at LinkedIn, on the health of the US labor market and economy
Rebecca Homkes, Faculty at the London Business School and at Duke Corporate Executive Education, on how executives should be evaluating the health of consumers, market concentration risk and AI bubble concerns
Bloomberg Tech Co-Host Ed Ludlow on Elon Musk’s SpaceX reportedly telling investors and financial institution representatives that it is aiming for an initial public offering in 2026
Bloomberg News Senior Editor, Equities Americas Eric Weiner recaps the week in markets and looks ahead to the Federal Reserve’s upcoming rate decision

Watch Bloomberg Businessweek Daily every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Netflix Inc.&nbsp;agreed to buy&nbsp;Warner Bros. Discovery Inc., marking a seismic shift in the entertainment business as a Silicon Valley-bred streaming giant tries to swallow one of Hollywood&rsquo;s oldest and most revered studios. Under terms of the deal&nbsp;announced&nbsp;Friday, Warner Bros. shareholders will receive $27.75 a share in cash and stock in Netflix, valuing the business at $82.7 billion including debt. The total equity value of the deal is $72 billion. Warner Bros. will spin off cable networks such as CNN and TNT into a separate company before concluding the sale of its studio and HBO to Netflix.&nbsp;
 Media mergers of this scale have a rocky history and this one is expected to bring intense regulatory scrutiny in the US and Europe.&nbsp;Paramount Skydance Corp., which accused Warner Bros. of running an unfair sales process, could also take steps to disrupt the transaction, like by taking an offer directly to shareholders. The company declined to comment. The Netflix deal combines two of the world&rsquo;s biggest streaming providers with some 450 million subscribers. Warner Bros.&rsquo; deep library of programming gives Netflix content to sustain its lead over challengers like Walt Disney Co. and Paramount. Today's show features:
<ul>
<li>Bloomberg News Media and Entertainment Editor Felix Gillette on Netflix agreeing to buy Warner Bros. Discovery Inc. in a deal valuing the business at $82.7 billion including debt</li>
<li>Karin Kimbrough, Chief Economist at LinkedIn, on the health of the US labor market and economy</li>
<li>Rebecca Homkes, Faculty at the London Business School and at Duke Corporate Executive Education, on how executives should be evaluating the health of consumers, market concentration risk and AI bubble concerns</li>
<li>Bloomberg Tech Co-Host Ed Ludlow on Elon Musk&rsquo;s SpaceX reportedly telling investors and financial institution representatives that it is aiming for an initial public offering in 2026</li>
<li>Bloomberg News Senior Editor, Equities Americas Eric Weiner recaps the week in markets and looks ahead to the Federal Reserve&rsquo;s upcoming rate decision</li>
</ul>

Netflix to Buy Warner Bros. in Historic $72 Billion Deal

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0f6aef00-7beb-4795-adf9-b3aa01742699/transcript

Dr. Nupoor Narula, MD, MSc is the Bruce Lerman Clinical Scholar, cardiologist, and Director of the Cardiology Vascular Laboratory and Women’s Heart Program at Weill Cornell Medicine. An NIH-funded physician-investigator, her clinical and research interests include genetic aortic diseases and aortic aneurysms and dissections, with a special emphasis on these conditions in women and pregnancy.

 
Dr. Narula recently received funding from the National Institutes of Health for her research on aortic aneurysms, and the NIH continues to fund related research in the area of women's heart health, which may signal a greater appetite to invest in, and prioritize an increasingly important clinical need. Dr. Narula details her work on cardiac risks to women, particularly during pregnancy, with Carol Massar and Alexis Christoforous on Bloomberg Businessweek Daily.

Dr. Nupoor Narula, MD, MSc is the Bruce Lerman Clinical Scholar, cardiologist, and Director of the Cardiology Vascular Laboratory and Women&rsquo;s Heart Program at Weill Cornell Medicine. An NIH-funded physician-investigator, her clinical and research interests include genetic aortic diseases and aortic aneurysms and dissections, with a special emphasis on these conditions in women and pregnancy.
&nbsp; Dr. Narula recently received funding from the National Institutes of Health for her research on aortic aneurysms, and the NIH continues to fund related research in the area of women's heart health, which may signal a greater appetite to invest in, and prioritize an increasingly important clinical need. Dr. Narula details her work on cardiac risks to women, particularly during pregnancy, with Carol Massar and Alexis Christoforous on Bloomberg Businessweek Daily.

NIH Backs Leading Cardiologist's Work on Women's Heart Health

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/5ec729a4-7cff-4a82-be62-b3aa0008d989/transcript

Florida's Canadian Meds, Taking the Higher Ground

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips